Science Explorer Back to mapMap

Most cited papers from Michigan Center for Translational Pathology

Michigan Center for Translational Pathology

What are the most cited papers from Michigan Center for Translational Pathology?

The most cited paper from Michigan Center for Translational Pathology is "Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018" (Lorenzo Galluzzi et al., 2018), with 6,760 citations. Next come "Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell Lymphoma" (4,157) and "The repertoire of mutational signatures in human cancer" (3,854).

Showing 50 of 60 papers. Every paper with more than 919 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018 Lorenzo Galluzzi et al. · Cell Death and Differentiation Open access169 authors 23 Jan 2018 6,760
2 Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell Lymphoma Stephen J. Schuster et al. · New England Journal of Medicine Open access Dec 2018 4,157
3 The repertoire of mutational signatures in human cancer Ludmil B. Alexandrov et al. · Nature Open access1,384 authors 5 Feb 2020 3,854
4 Integrative Clinical Genomics of Advanced Prostate Cancer Dan R. Robinson et al. · Cell Open access May 2015 3,727
5 Docetaxel and Estramustine Compared with Mitoxantrone and Prednisone for Advanced Refractory Prostate Cancer Daniel Peter Petrylak, Catherine M. Tangen, Maha Hussain et al. · New England Journal of Medicine Open access 6 Oct 2004 3,706
6 Oncogenic Signaling Pathways in The Cancer Genome Atlas Francisco Sánchez-Vega et al. · Cell Open access779 authors Apr 2018 3,452
7 Pan-cancer analysis of whole genomes Lauri A. Aaltonen et al. · Nature Open access1,324 authors 5 Feb 2020 3,360
8 A reference panel of 64,976 haplotypes for genotype imputation Shane McCarthy et al. · Nature Genetics Open access111 authors 22 Aug 2016 3,318
9 CD8+ T cells regulate tumour ferroptosis during cancer immunotherapy Weimin Wang et al. · Nature Open access May 2019 2,952
10 The landscape of long noncoding RNAs in the human transcriptome Matthew K. Iyer, Yashar S. Niknafs, Rohit Malik et al. · Nature Genetics Open access 19 Jan 2015 2,921
11 Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer Christopher J. Sweeney, Yu‐Hui Chen, Michael Anthony Carducci et al. · New England Journal of Medicine Open access 5 Aug 2015 2,915
12 ProteomeXchange provides globally coordinated proteomics data submission and dissemination Juan Antonio Vizcaíno et al. · Nature Biotechnology Open access Mar 2014 2,912
13 The polycomb group protein EZH2 is involved in progression of prostate cancer Sooryanarayana Varambally, Saravana Mohan Dhanasekaran, Ming Zhou et al. · Nature Open access Oct 2002 2,740
14 UALCAN: An update to the integrated cancer data analysis platform Darshan Shimoga Chandrashekar, Santhosh Kumar Karthikeyan, Praveen Kumar Korla et al. · Neoplasia Open access 22 Jan 2022 2,635
15 The mutational landscape of lethal castration-resistant prostate cancer Catherine S. Grasso et al. · Nature Open access 18 May 2012 2,622
16 Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy Nisha Nagarsheth, Max S. Wicha, Weiping Zou · Nature reviews. Immunology ReviewOpen access 30 May 2017 2,379
17 Role of the gut microbiota in immunity and inflammatory disease Nobuhiko Kamada, Sang‐Uk Seo, Grace Chen et al. · Nature reviews. Immunology Review 25 Apr 2013 2,285
18 Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression Arun Sreekumar et al. · Nature Open access Feb 2009 2,269
19 K+ Efflux Is the Common Trigger of NLRP3 Inflammasome Activation by Bacterial Toxins and Particulate Matter Raúl Muñoz-Planillo, Peter Kuffa, Giovanny J. Martínez-Colón et al. · Immunity Open access Jun 2013 2,200
20 The Landscape of Circular RNA in Cancer Josh N. Vo, Marcin P. Cieslik, Yajia Zhang et al. · Cell Open access Feb 2019 2,070
21 20-Year Risks of Breast-Cancer Recurrence after Stopping Endocrine Therapy at 5 Years Hongchao Pan, Richard G. Gray, Jeremy P. Braybrooke et al. · New England Journal of Medicine Open access 8 Nov 2017 1,883
22 Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015 Alan Stuart Coates et al. · Annals of Oncology Open access 4 May 2015 1,865
23 The inflammasome: a caspase-1-activation platform that regulates immune responses and disease pathogenesis Luigi Franchi, Tatjana Eigenbrod, Raúl Muñoz-Planillo et al. · Nature Immunology Open access 17 Feb 2009 1,863
24 The Emergence of lncRNAs in Cancer Biology John R. Prensner, Arul M. Chinnaiyan · Cancer Discovery Open access Oct 2011 1,825
25 Nod2-Dependent Regulation of Innate and Adaptive Immunity in the Intestinal Tract Koichi S. Kobayashi, Mathias Chamaillard, Yasunori Ogura et al. · Science 3 Feb 2005 1,777
26 Gut microbiota: Role in pathogen colonization, immune responses, and inflammatory disease Joseph M. Pickard, Melody Y. Zeng, Roberta Caruso et al. · Immunological Reviews ReviewOpen access 30 Aug 2017 1,753
27 The Role of Non-coding RNAs in Oncology Frank John Slack, Arul M. Chinnaiyan · Cell Open access Nov 2019 1,746
28 Delineation of prognostic biomarkers in prostate cancer Saravana Mohan Dhanasekaran, Terrence R. Barrette, Debashis Ghosh et al. · Nature Open access Aug 2001 1,691
29 Control of pathogens and pathobionts by the gut microbiota Nobuhiko Kamada, Grace Chen, Naohiro Inohara et al. · Nature Immunology Open access 18 Jun 2013 1,657
30 Initial genome sequencing and analysis of multiple myeloma Michael A. Chapman et al. · Nature Open access Mar 2011 1,472
31 Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial Kathy S. Albain et al. · The Lancet Oncology Open access 12 Dec 2009 1,418
32 Cancer Stem Cells: An Old Idea—A Paradigm Shift Max S. Wicha, Suling Liu, Gabriela Dontu · Cancer Research 15 Feb 2006 1,382
33 Nod2, a Nod1/Apaf-1 Family Member That Is Restricted to Monocytes and Activates NF-κB Yasunori Ogura, Naohiro Inohara, Adalberto Benito et al. · Journal of Biological Chemistry Open access Feb 2001 1,377
34 Regional Nodal Irradiation in Early-Stage Breast Cancer Timothy Joseph Whelan et al. · New England Journal of Medicine Open access 22 Jul 2015 1,324
35 De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017 Giuseppe Curigliano et al. · Annals of Oncology Open access 11 Jun 2017 1,263
36 Gene expression–based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study Kerby Shedden et al. · Nature Medicine Open access 20 Jul 2008 1,253
37 Epigenetic silencing of TH1-type chemokines shapes tumour immunity and immunotherapy Dongjun Peng, Ilona Kryczek, Nisha Nagarsheth et al. · Nature Open access 26 Oct 2015 1,219
38 Further development and validation of empirical scoring functions for structure-based binding affinity prediction Renxiao Wang, Luhua Lai, Shaomeng Wang · Journal of Computer-Aided Molecular Design Open access 2002 1,205
39 Activating ESR1 mutations in hormone-resistant metastatic breast cancer Dan R. Robinson et al. · Nature Genetics Open access 3 Nov 2013 1,177
40 Bacterial RNA and small antiviral compounds activate caspase-1 through cryopyrin/Nalp3 Thirumala‐Devi Kanneganti, Nesrin Özören, Mathilde Body–Malapel et al. · Nature 11 Jan 2006 1,150
41 The evolutionary history of 2,658 cancers Moritz Gerstung et al. · Nature Open access1,441 authors 5 Feb 2020 1,149
42 Circulating Tumor Cells: A Novel Prognostic Factor for Newly Diagnosed Metastatic Breast Cancer Massimo Cristofanilli, Daniel F.C. Hayes, George Thomas Budd et al. · Journal of Clinical Oncology Open access 26 Feb 2005 1,139
43 Microsatellite instability in colorectal cancer—the stable evidence Eduardo Vilar, Stephen B. Gruber · Nature Reviews Clinical Oncology ReviewOpen access 9 Feb 2010 1,102
44 Radiotherapy and Immunotherapy Promote Tumoral Lipid Oxidation and Ferroptosis via Synergistic Repression of SLC7A11 Xueting Lang et al. · Cancer Discovery Open access 25 Sep 2019 1,094
45 Diabetes: a 21st century challenge Paul Zimmet, Dianna J. Magliano, William H. Herman et al. · The Lancet Diabetes & Endocrinology 3 Dec 2013 1,094
46 Intracellular NOD-like Receptors in Host Defense and Disease Thirumala‐Devi Kanneganti, Mohamed Lamkanfi, Gabriel Núñez · Immunity Open access Oct 2007 1,069
47 Genomic Loss of microRNA-101 Leads to Overexpression of Histone Methyltransferase EZH2 in Cancer Sooryanarayana Varambally, Qi Ling Cao, Ram Shankar Mani et al. · Science Open access 13 Nov 2008 1,060
48 Caspases: the proteases of the apoptotic pathway Gabriel Núñez, Mary Benedict, Yuanmimg Hu et al. · Oncogene 24 Dec 1998 1,051
49 Transcriptome sequencing across a prostate cancer cohort identifies PCAT-1, an unannotated lincRNA implicated in disease progression John R. Prensner, Matthew K. Iyer, O. Alejandro Balbin et al. · Nature Biotechnology Open access 31 Jul 2011 1,047
50 Aldehyde Dehydrogenase 1 Is a Marker for Normal and Malignant Human Colonic Stem Cells (SC) and Tracks SC Overpopulation during Colon Tumorigenesis Emina H. Huang, Mark J. Hynes, Tao Zhang et al. · Cancer Research Open access Apr 2009 1,043

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.